This brand name is authorized in Ecuador
The drug NORAVER P contains a combination of these active pharmaceutical ingredients (APIs):
|
1
Benzocaine
UNII U3RSY48JW5 - BENZOCAINE
|
|
Benzocaine is a local anaesthetic of the ester type, acting to produce reversible loss of sensation by preventing or diminishing the generation and transmission of sensory nerve impulses near the site of application. Depolarisation of the neuronal membrane and ion exchange are reversibly inhibited. |
|
2
Cetylpyridinium
UNII D9OM4SK49P - CETYLPYRIDINIUM CHLORIDE
|
|
Cetylpyridinium is an antiseptic with activity against both gram positive and gram negative organisms. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| R02AD01 | Benzocaine | R Respiratory system → R02 Throat preparations → R02A Throat preparations → R02AD Anesthetics, local |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: EC | Agencia Nacional de Regulación, Control y Vigilancia Sanitaria | Identifier(s): H2461112 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
